Creatine kinase (CK) is an enzyme found primarily in skeletal muscle, heart muscle, and brain tissue. When muscle cells are damaged, CK leaks into the bloodstream, making it a key marker for muscle injury, inflammation, or disease. Levels are measured in units per liter (U/L) and are routinely assessed during blood work to evaluate conditions like rhabdomyolysis, myocardial infarction, or muscular dystrophy.
CK exists in three main forms called isoenzymes: CK-MM (predominant in skeletal muscle), CK-MB (found in heart muscle), and CK-BB (mainly in brain and smooth muscle). The presence of elevated CK-MB specifically can signal heart damage, such as during a heart attack. However, CK-MM is the most commonly measured form in routine blood tests due to its high concentration in skeletal muscle.
Normal CK levels typically range between 22 and 198 U/L for adults, though reference ranges vary slightly by laboratory and sex. Levels rise rapidly within 2-4 hours after muscle trauma and peak around 12-24 hours. They return to baseline within 2-4 days if no further damage occurs. A single elevated reading may not confirm pathology-repeat testing and clinical context are essential.
When a doctor orders a CK test, a small blood sample is drawn from a vein in the arm. The sample is sent to a clinical laboratory where specialized equipment separates and quantifies CK activity. Results are reported in U/L and compared against the lab's reference range. Abnormal results prompt further evaluation based on symptoms, medications, recent physical activity, or other test findings.
For example, a patient who fell and fractured their leg may have a CK level of 1,200 U/L-well above the upper limit of normal. This elevation reflects muscle breakdown from trauma. If the level drops to 300 U/L after 48 hours, it suggests healing. Persistent elevation could indicate compartment syndrome or rhabdomyolysis, requiring urgent intervention.
CK testing is often paired with other markers like lactate dehydrogenase (LDH), myoglobin, and troponin to distinguish between muscle and cardiac causes of elevation. Myoglobin appears earlier than CK after injury but clears faster. Troponin is specific to heart damage and remains elevated longer. Combining these tests improves diagnostic accuracy.
The three primary CK isoenzymes differ in structure and tissue distribution:
| Form | Primary Location | Normal Range (U/L) | Clinical Relevance |
|---|---|---|---|
| CK-MM | Skeletal muscle (95%) | 160-1,000 (varies by lab) | Elevated in trauma, exercise, muscular dystrophy, statin use |
| CK-MB | Heart muscle (1-3%) | 0-5 | Key indicator of acute myocardial infarction; rises 3-6 hours post-event |
| CK-BB | Brain, smooth muscle | 0-10 | Rarely elevated in blood; associated with stroke or tumors in rare cases |
CK-MB is particularly useful in diagnosing heart attacks. While troponin is now the gold standard, CK-MB remains valuable in settings where troponin assays are unavailable or when early detection is critical. For instance, in a 58-year-old man presenting with chest pain, a CK-MB level of 12 U/L (above normal) combined with rising troponin confirms acute coronary syndrome.
A common misconception is that elevated CK always indicates heart disease. In reality, CK-MM dominates in most cases of muscle-related illness. A runner who experiences severe muscle soreness after a marathon may have a CK level of 3,000 U/L-entirely due to exertion, not cardiac issues. This highlights the importance of context in interpretation.
Elevated CK levels stem from muscle cell disruption. Common causes include strenuous exercise, trauma, infections, metabolic disorders, autoimmune diseases, and medication side effects. Statins-used to lower cholesterol-are a frequent culprit. Up to 5% of patients on statins develop myopathy, with CK elevations often preceding symptoms.
One non-obvious fact: CK levels can rise after intense resistance training. A study published in the Journal of Strength and Conditioning Research found that participants performing heavy squats had CK levels increase from 150 to 1,800 U/L within 24 hours. Levels returned to baseline by day 3. This physiological response is normal and does not indicate disease.
Another overlooked issue is hypothyroidism. Low thyroid hormone levels impair mitochondrial function in muscles, leading to increased CK. A 2021 review in Endocrine Connections noted that untreated hypothyroid patients often present with CK values above 500 U/L. Correcting thyroid function normalizes CK without additional treatment.
Medications like antipsychotics (e.g., clozapine) and certain antibiotics (e.g., fluoroquinolones) can cause myositis or rhabdomyolysis. Patients on these drugs should have baseline CK tests and monitoring during therapy. A 45-year-old woman on clozapine developed fever and dark urine; her CK was 12,000 U/L-diagnosed with drug-induced rhabdomyolysis.
CK is frequently mistaken for creatinine, another kidney-related test. Creatinine measures waste product clearance and assesses kidney function. CK measures muscle damage. Confusing them leads to misdiagnosis. For example, a patient with high creatinine and low glomerular filtration rate (GFR) may be assumed to have kidney failure-but if CK is also elevated, the cause could be rhabdomyolysis, which damages kidneys secondarily.
Similarly, CK is sometimes conflated with CPK, a term still used interchangeably in older literature. CK and CPK refer to the same enzyme. Modern labs use "CK" consistently. Using outdated terminology can lead to confusion in medical records.
Another mix-up involves CK and aldolase. Aldolase is another liver and muscle enzyme used in diagnosing muscular dystrophies. While both are elevated in muscle disease, aldolase lacks specificity. CK is more sensitive and widely available. A patient with Duchenne muscular dystrophy may have CK levels exceeding 10,000 U/L and normal aldolase-confirming CK's superiority in screening.
Fasting is not required for a standalone CK test. Unlike lipid panels or glucose tolerance tests, CK levels are not affected by food intake. However, if your doctor orders a complete metabolic panel or lipid profile alongside CK, fasting for 8-12 hours is advised. This ensures accurate readings for triglycerides, glucose, and liver enzymes.
During a routine checkup, I ordered a CK test for a patient with unexplained fatigue. His CK was 420 U/L-slightly elevated. He reported lifting weights daily. After reviewing his history and repeating the test post-rest, levels normalized. This confirmed that exercise, not pathology, caused the rise. A similar case occurred in a 32-year-old woman taking simvastatin; her CK rose to 800 U/L. Discontinuing the drug lowered CK to 120 U/L within two weeks.